Table I.
Demographic characteristics of HF and non-HF patients.
| Variables | HF patients (n=9) | Non-HF patients (n=8) | P-value |
|---|---|---|---|
| Age, years (mean ± standard deviation) | 60.1±14.3 | 51.8±7.2 | 0.147 |
| Male sex, n (%) | 6 (66.7) | 7 (87.5) | 0.576 |
| Body mass index, kg/m2 (mean ± standard deviation) | 26.8±3.1 | 25.6±1.6 | 0.323 |
| Hypertension, n (%) | 3 (33.3) | 1 (12.5) | 0.576 |
| Diabetes, n (%) | 2 (22.2) | 1 (12.5) | >0.999 |
| Smoking, n (%) | 3 (33.3) | 5 (62.5) | 0.347 |
| Hypercholesterolemia, n (%) | 5 (55.6) | 4 (50.0) | >0.999 |
| Previous MI, n (%) | 0 (0.0) | 0 (0.0) | NA |
| AMI, n (%) | 8 (88.9) | 3 (37.5) | 0.106 |
| Aspirin, n (%) | 9 (100.0) | 8 (100.0) | NA |
| Clopidogrel, n (%) | 8 (88.9) | 8 (100.0) | >0.999 |
| β-blockers, n (%) | 9 (100.0) | 8 (100.0) | NA |
| ACE inhibitors, n (%) | 9 (100.0) | 8 (100.0) | NA |
| Statins, n (%) | 9 (100.0) | 8 (100.0) | NA |
| Diuretics, n (%) | 7 (77.8) | 1 (12.5) | 0.015 |
| NT-proBNP, pg/ml (mean ± standard deviation) | 918.3±848.5 | 62.0±14.1 | <0.001 |
| LVEF, % (mean ± standard deviation) | 39.3±8.4 | 66.8±1.9 | 0.001 |
HF, heart failure; ACE, angiotensin-converting enzyme; AMI, acute myocardial infarction; MI, myocardial infarction; NT-proBNP, N-terminal pro-brain natriuretic peptide; LVEF, left ventricular ejection fraction.